Total Payments
$1,805
2022 Payments
$52.65
Companies
19
Transactions
92
Medicare Patients
7,659
Medicare Billing
$761,824
Payment Breakdown by Category
Food & Beverage$1,431 (79.3%)
Education$373.50 (20.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,431 | 88 | 79.3% |
| Education | $373.50 | 4 | 20.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $547.06 | 38 | $0 (2022) |
| Janssen Biotech, Inc. | $273.73 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $199.46 | 7 | $0 (2019) |
| Genentech USA, Inc. | $184.77 | 12 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $163.97 | 6 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $90.50 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $76.50 | 4 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $50.49 | 4 | $0 (2018) |
| TESARO, Inc. | $47.88 | 3 | $0 (2017) |
| PFIZER INC. | $26.96 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $52.65 | 3 | Novartis Pharmaceuticals Corporation ($19.77) |
| 2019 | $750.14 | 33 | Novartis Pharmaceuticals Corporation ($231.48) |
| 2018 | $367.07 | 20 | Pharmacyclics LLC, An AbbVie Company ($144.45) |
| 2017 | $635.03 | 36 | Novartis Pharmaceuticals Corporation ($295.81) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2022 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2022 | Celgene Corporation | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $18.10 | General |
| Category: Oncology | ||||||
| 02/14/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/15/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2019 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $85.00 | General |
| Category: Oncology | ||||||
| 09/27/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Oncology | ||||||
| 08/09/2019 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2019 | Takeda Pharmaceuticals U.S.A., Inc. | VELCADE (Drug) | Education | In-kind items and services | $90.50 | General |
| Category: Oncology | ||||||
| 06/06/2019 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: BioOncology | ||||||
| 06/03/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2019 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: BioOncology | ||||||
| 05/13/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: ONCOLOGY | ||||||
| 05/06/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Oncology | ||||||
| 05/06/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2019 | Novartis Pharmaceuticals Corporation | SANDOSTATIN (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: Oncology | ||||||
| 04/16/2019 | Genentech USA, Inc. | Perjeta (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: BioOncology | ||||||
| 04/16/2019 | Genentech USA, Inc. | Perjeta (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: BioOncology | ||||||
| 04/09/2019 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Immunology | ||||||
| 04/08/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 31 | 2,021 | 8,957 | $749,630 | $204,974 |
| 2021 | 36 | 2,686 | 17,745 | $1.1M | $311,230 |
| 2020 | 44 | 2,952 | 18,119 | $948,009 | $245,620 |
Total Patients
7,659
Total Services
44,821
Medicare Billing
$761,824
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 3 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2021 | 68 | 73 | $5,110 | $1,519 | 29.7% |
| 96361 | Hydration infusion into a vein | Office | 2021 | 13 | 98 | $4,900 | $1,359 | 27.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 57 | 77 | $3,850 | $1,161 | 30.2% |
| 83550 | Iron binding capacity | Office | 2021 | 65 | 123 | $3,690 | $1,068 | 28.9% |
| 82746 | Folic acid level, serum | Office | 2021 | 54 | 72 | $3,600 | $1,019 | 28.3% |
| 83540 | Iron level | Office | 2021 | 65 | 121 | $2,420 | $777.30 | 32.1% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2021 | 56 | 83 | $2,905 | $429.94 | 14.8% |
| 86430 | Rheumatoid factor analysis | Office | 2021 | 43 | 45 | $900.00 | $276.30 | 30.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 15 | 15 | $825.00 | $252.00 | 30.5% |
| 83090 | Homocysteine (amino acid) level | Office | 2021 | 14 | 14 | $770.00 | $250.88 | 32.6% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2021 | 73 | 86 | $860.00 | $232.20 | 27.0% |
| 85730 | Coagulation assessment blood test, plasma or whole blood | Office | 2021 | 15 | 18 | $360.00 | $108.18 | 30.1% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2021 | 34 | 148 | $740.00 | $80.54 | 10.9% |
| 85610 | Blood test, clotting time | Office | 2021 | 14 | 18 | $270.00 | $77.22 | 28.6% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2021 | 11 | 82 | $410.00 | $54.74 | 13.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 13 | 13 | $130.00 | $41.21 | 31.7% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2021 | 12 | 26 | $130.00 | $28.66 | 22.0% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2020 | 16 | 8,000 | $224,500 | $54,503 | 24.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 172 | 595 | $154,700 | $40,118 | 25.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 170 | 381 | $144,520 | $35,782 | 24.8% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 37 | 163 | $84,760 | $23,109 | 27.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 66 | 98 | $49,980 | $13,496 | 27.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 258 | 863 | $30,205 | $9,038 | 29.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 306 | 1,169 | $29,225 | $8,996 | 30.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 35 | 35 | $25,550 | $6,710 | 26.3% |
About Dr. Paula Schwartz, M.D
Dr. Paula Schwartz, M.D is a Specialist healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780769877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paula Schwartz, M.D has received a total of $1,805 in payments from pharmaceutical and medical device companies, with $52.65 received in 2022. These payments were reported across 92 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,431).
As a Medicare-enrolled provider, Schwartz has provided services to 7,659 Medicare beneficiaries, totaling 44,821 services with total Medicare billing of $761,824. Data is available for 3 years (2020–2022), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location New Hyde Park, NY
- Active Since 10/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1780769877
Products in Payments
- TASIGNA (Drug) $173.71
- Imbruvica (Drug) $163.97
- IMBRUVICA (Drug) $141.24
- PROMACTA (Drug) $128.41
- DARZALEX (Biological) $106.44
- KEYTRUDA (Biological) $100.22
- VELCADE (Drug) $90.50
- JADENU (Drug) $84.56
- OPDIVO (Biological) $76.50
- MEKINIST (Drug) $73.09
- Perjeta (Biological) $58.07
- BENDEKA (Drug) $50.49
- ZEJULA (Drug) $47.88
- SANDOSTATIN (Drug) $41.59
- TECENTRIQ (Biological) $38.03
- GAZYVA (Biological) $29.18
- Erleada (Drug) $26.05
- PIQRAY (Drug) $19.77
- Cabometyx (Drug) $19.47
- ONUREG (Drug) $18.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New Hyde Park
Dr. Elliott Salamon, Do, DO
Specialist — Payments: $52,956
Specialist $52,956
Dr. Andrew Porges, Md, MD
Specialist — Payments: $30,781
Specialist $30,781
Dr. Ivan Pavkovic, M.d, M.D
Specialist — Payments: $29,318
Specialist $29,318
Dr. Joseph Ramek, M.d, M.D
Specialist — Payments: $26,475
Specialist $26,475
Dr. Slavina Gardella, M.d, M.D
Specialist — Payments: $23,827
Specialist $23,827
Victor Katz, Md, MD
Specialist — Payments: $19,161
Specialist $19,161